Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Nasopharyngeal Cancer – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Nasopharyngeal Cancer –…
DUBLIN–(BUSINESS WIRE)–The “Osteosarcoma – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Osteosarcoma – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Osteoarthritis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Osteoarthritis – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Diabetic Macular Edema – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Diabetic Macular…
DUBLIN–(BUSINESS WIRE)–The “Sepsis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Sepsis – Pipeline Review,…
The company is commercializing its FDA-cleared bio-ConneKt® Wound Matrix to the advance wound care market. ALACHUA, Fla.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/MLMBiologics?src=hash" target="_blank"gt;#MLMBiologicslt;/agt;–UF…
Represents the Fourth Innovus Pharma Product Notification in the E.U. SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”)…
TORTOLA, British Virgin Islands–(BUSINESS WIRE)–Juvenescence, a life sciences company developing therapeutics and technologies to treat diseases of aging and increase…
Enables new sites to participate in the European Phase III SALAMANDER trials LONDON–(BUSINESS WIRE)–Rexgenero, a regenerative medicine company developing advanced…
Transgene confirms that the study’s primary
endpoint (objective response rate – ORR) on a minimum of 35 evaluable
patients will be reported in Q4 2019.